Immune determinants of the pre-metastatic niche
Cancer Cell · 2023-03 · 41 (3) · 546-572
DOI: 10.1016/j.ccell.2023.02.018 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Cell, 2023-03. Verfasst von Laura Patras und 3 weiteren Autor:innen. Beteiligte Einrichtung: Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's …. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 241-mal zitiert (Crossref) und nennt 304 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS, Hartwell Foundation.
Abstract (Originalsprache)
Primary tumors actively and specifically prime pre-metastatic niches (PMNs), the future sites of organotropic metastasis, preparing these distant microenvironments for disseminated tumor cell arrival. While initial studies of the PMN focused on extracellular matrix alterations and stromal reprogramming, it is increasingly clear that the far-reaching effects of tumors are in great part achieved through systemic and local PMN immunosuppression. Here, we discuss recent advances in our understanding of the tumor immune microenvironment and provide a comprehensive overview of the immune determinants of the PMN's spatiotemporal evolution. Moreover, we depict the PMN immune landscape, based on functional pre-clinical studies as well as mounting clinical evidence, and the dynamic, reciprocal crosstalk with systemic changes imposed by cancer progression. Finally, we outline emerging therapeutic approaches that alter the dynamics of the interactions driving PMN formation and reverse immunosuppression programs in the PMN ensuring early anti-tumor immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA…
- Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- Hartwell Foundation
- Starr Foundation
- Thompson Family Foundation
- National Cancer Institute
- Simons Foundation
- Children's Cancer and Blood Foundation
Zitieren
APA
Patras, L., Shaashua, L., Matei, I., & Lyden, D. (2023). Immune determinants of the pre-metastatic niche. Cancer Cell, 41(3), 546-572. https://doi.org/10.1016/j.ccell.2023.02.018
Vancouver
Patras L, Shaashua L, Matei I, Lyden D. Immune determinants of the pre-metastatic niche. Cancer Cell. 2023;41(3):546-572. doi:10.1016/j.ccell.2023.02.018
BibTeX
@article{Patras2023,
author = {Patras, Laura and Shaashua, Lee and Matei, Irina and Lyden, David},
title = {Immune determinants of the pre-metastatic niche},
journal = {Cancer Cell},
year = {2023},
volume = {41},
number = {3},
pages = {546--572},
doi = {10.1016/j.ccell.2023.02.018}
}
EUVIMED